GSK580299
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK580299, covering 2011-03-24 to 2011-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. [Phase 3]